James Sidoti
Stock Analyst at Sidoti & Co.
(1.90)
# 1,692
Out of 4,479 analysts
7
Total ratings
60%
Success rate
71.66%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRDX Surmodics | Downgrades: Neutral | $43 | $41.97 | +2.45% | 1 | May 29, 2024 | |
| STAA STAAR Surgical Company | Upgrades: Buy | n/a | $44.52 | - | 2 | Nov 7, 2022 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $5 | $1.23 | +306.50% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | n/a | $81.19 | - | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | n/a | $26.03 | - | 1 | Jan 21, 2020 |
Surmodics
May 29, 2024
Downgrades: Neutral
Price Target: $43
Current: $41.97
Upside: +2.45%
STAAR Surgical Company
Nov 7, 2022
Upgrades: Buy
Price Target: n/a
Current: $44.52
Upside: -
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $5
Current: $1.23
Upside: +306.50%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: n/a
Current: $81.19
Upside: -
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $26.03
Upside: -